Categoria
Hypertil
Nombres de marca,
Hypertil
Analogos
Hypertil
Marca los nombres de mezcla
No information avaliable
Hypertil
Formula quimica
C9H15NO3S
Hypertil
RX enlace
http://www.rxlist.com/cgi/generic/captop.htm
Hypertil
FDA hoja
Hypertil
MSDS (hoja de seguridad de materiales)
Hypertil
Sintesis de referencia
DW Cushman, EE.UU. Pat. 4,046,889 (1977)
Hypertil
Peso molecular
217.286 g/mol
Hypertil
Punto de fusion
106oC
Hypertil
H2O Solubilidad
Muy soluble
Hypertil
Estado
Solid
Hypertil
LogP
0.546
Hypertil
Formas de dosificacion
Tablet (12,5 mg, 25 mg, 50 mg o 100 mg)
Hypertil
Indicacion
Para el tratamiento de la hipertensión. Se puede utilizar solo o en combinación con diuréticos tiazídicos.
Hypertil
Farmacologia
Captopril, un inhibidor de la enzima convertidora de angiotensina (ECA), se utiliza para tratar la hipertensión, insuficiencia cardiaca congestiva, y síndromes renales como la nefropatía diabética y la esclerodermia. El efecto adverso y las limitaciones farmacocinéticas del captopril estimulado el desarrollo de inhibidores de la ECA enalapril y posteriores.
Hypertil
Absorcion
75% sin alimentos (la presencia de alimentos en el tracto gastrointestinal reduce la absorción de unos 30 a 40 por ciento).
Hypertil
Toxicidad
Los síntomas de sobredosis incluyen coma, letargo, baja presión arterial, la lentitud, y el estómago e irritación intestinal y la hiperactividad.
Hypertil
Informacion de Pacientes
Patients should be advised to immediately report to their physician any signs or symptoms suggesting angioedema
(e.g., swelling of face, eyes, lips, tongue, larynx and extremities; difficulty in swallowing or breathing;
hoarseness) and to discontinue therapy.
Patients should be told to report promptly any indication of infection (e.g., sore throat, fever),which may be a
sign of neutropenia, or of progressive edema which might be related to proteinuria and nephrotic syndrome.
All patients should be cautioned that excessive perspiration and dehydration may lead to an excessive fall in
blood pressure because of reduction in fluid volume. Other causes of volume depletion such as vomiting or diarrhea
may also lead to a fall in blood pressure; patients should be advised to consult with the physician.
Patients should be advised not to use potassium-sparing diuret-ics, potassium supplements or potassium-containing
salt substitutes without consulting their physician.
Patients should be warned against interruption or discontinuation of medication unless instructed by the
physician.
Heart failure patients on captopril therapy should be cautioned against rapid increases in physical activity.
Patients should be informed that captopril should be taken one hour before meals.
Hypertil
Organismos afectados
Humanos y otros mamíferos